
IDEX (IEX) Stock Forecast & Price Target
IDEX (IEX) Analyst Ratings
Bulls say
IDEX is well-positioned for future growth with its strong financials, decentralized structure, and focus on high-growth industries. The company's strategic initiatives and improved organic sales outlook are expected to drive strong performance in the future. However, there are potential risks from external factors, and the company's neutral rating reflects these uncertainties.
Bears say
IDEX is a diversified industrial company that has historically been a high-quality industrial compounder, but over the past three years, the company's growth, profitability, and ROIC have been impacted by challenges in certain end markets (such as life sciences and semiconductors) and its pursuit of growthier acquisitions at higher multiples. While the company's pivot to targeted/integrated growth platforms has translated to strong orders in its health and science technologies segment and its balance sheet allows for ample capital optionality, there are still potential risks from tariffs, inventory resets, short-cycle businesses, and the impact of COVID-19. Overall, despite the company's strong fundamentals, the negative outlook is driven by concerns about its recent performance in key markets and potential risks in the future.
This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.
IDEX (IEX) Analyst Forecast & Price Prediction
Start investing in IDEX (IEX)
Order type
Buy in
Order amount
Est. shares
0 shares